Related Experiment Videos
Expression of TRbeta1 mRNAs with functionally impaired mutations is rare in thyroid papillary carcinoma
Toru Takano1, Akira Miyauchi, Hiroshi Yoshida
1Department of Laboratory Medicine, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan. ttakano@labo.med.osaka-u.ac.jp
Abstract:
A previous study reported the expression of functionally impaired thyroid hormone receptor (TR)beta1 mutants in almost all papillary thyroid carcinomas. To confirm this, we analyzed the sequence of the entire coding region of TRbeta1 cDNAs expressed in 16 papillary carcinomas. Among the 48 clones analyzed, we found no mutations with an amino acid substitution, which represents a clear discrepancy between our findings and those in the previous study. Our findings suggest that the expression of functionally impaired mutants in papillary carcinomas is rare, and they raise a question about the possible role of mutated TRbeta1 in the tumorigenesis of papillary carcinoma.
Insights
Functionally impaired thyroid hormone receptor (TR)beta1 mutants are rarely expressed in papillary thyroid carcinomas, contradicting previous findings. This suggests mutated TRbeta1 may not play a significant role in thyroid cancer development.
Area of Science:
- Endocrinology
- Oncology
- Molecular Biology
Background:
- Previous research suggested widespread expression of mutated thyroid hormone receptor beta1 (TRbeta1) in papillary thyroid carcinomas.
- These mutations were thought to impair TRbeta1 function, potentially contributing to thyroid cancer.
- A discrepancy exists regarding the prevalence and role of TRbeta1 mutations in papillary thyroid carcinoma.
Purpose of the Study:
- To investigate the presence and frequency of TRbeta1 mutations in papillary thyroid carcinomas.
- To reconcile conflicting findings from previous studies on TRbeta1 in thyroid cancer.
Main Methods:
- Analysis of the entire coding region of TRbeta1 cDNAs.
- Sequencing of 48 cDNA clones from 16 papillary carcinoma samples.
Main Results:
- No mutations resulting in amino acid substitutions in TRbeta1 were detected in the analyzed samples.
- This finding directly contradicts the results of a prior study.
- The expression of functionally impaired TRbeta1 mutants in papillary carcinomas appears to be infrequent.
Conclusions:
- The expression of functionally impaired TRbeta1 mutants in papillary thyroid carcinomas is likely rare.
- The role of mutated TRbeta1 in the development of papillary thyroid carcinoma is questionable.
- Further research is needed to clarify the specific mutations and their impact on thyroid tumorigenesis.